• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先前暴露于 delta9-四氢大麻酚会增强对安非他命的运动反应,但不会增强其自身给药。

Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine.

机构信息

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA.

出版信息

J Pharmacol Exp Ther. 2011 Jun;337(3):724-33. doi: 10.1124/jpet.111.180208. Epub 2011 Mar 9.

DOI:10.1124/jpet.111.180208
PMID:21389094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3101004/
Abstract

Previous exposure to amphetamine leads to enhanced locomotor and nucleus accumbens (NAcc) dopamine (DA) responding to the drug as well as enhanced amphetamine self-administration. Here, we investigated the effects of exposure to Δ(9)-tetrahydrocannibinol (Δ(9)-THC) on behavioral and biochemical responding to amphetamine. Rats in different groups received five exposure injections of vehicle or one of five doses of Δ(9)-THC (0.4, 0.75, 1.5, 3.0, and 6.0 mg/kg i.p.) and were tested 2 days and 2 weeks later. Exposure to all but the lowest and highest doses of Δ(9)-THC enhanced the locomotor response to amphetamine (0.75 mg/kg i.p.), but all failed to enhance NAcc DA overflow in response to the drug. Moreover, exposure to 3.0 mg/kg i.p. Δ(9)-THC increased forskolin-evoked adenylyl cyclase activity in the NAcc and rats' locomotor response to the direct DA receptor agonist apomorphine (1.0 mg/kg s.c.), suggesting that Δ(9)-THC sensitized locomotor responding to amphetamine by up-regulating postsynaptic DA receptor signaling in the NAcc. Finally, amphetamine self-administration (200 μg/kg/infusion i.v.) was enhanced in amphetamine (5 × 1.5 mg/kg i.p.)-exposed rats, but not in rats exposed to Δ(9)-THC (5 × 3.0 mg/kg i.p.). Previous exposure to this dose of Δ(9)-THC modestly increased apomorphine SA (0.5 mg/kg/infusion i.v.). Thus, unlike amphetamine exposure, exposure to Δ(9)-THC does not enhance the subsequent NAcc DA response to amphetamine or promote amphetamine self-administration. Although Δ(9)-THC leads to alterations in postsynaptic DA receptor signaling in the NAcc and these can affect the generation of locomotion, these neuroadaptations do not seem to be linked to the expression of enhanced amphetamine self-administration.

摘要

先前暴露于安非他命会导致对药物的运动和伏隔核(NAcc)多巴胺(DA)反应增强,以及增强安非他命的自我给药。在这里,我们研究了暴露于Δ(9)-四氢大麻酚(Δ(9)-THC)对安非他命的行为和生化反应的影响。不同组的大鼠接受了五次载体或五次剂量的Δ(9)-THC(0.4、0.75、1.5、3.0 和 6.0 mg/kg 腹腔注射)的暴露注射,并在 2 天和 2 周后进行测试。除了最低和最高剂量外,所有暴露于Δ(9)-THC 的剂量都增强了对安非他命(0.75 mg/kg 腹腔注射)的运动反应,但都未能增强对药物的 NAcc DA 溢出。此外,暴露于 3.0 mg/kg 腹腔注射Δ(9)-THC 增加了 NAcc 中 forskolin 诱导的腺苷酸环化酶活性,以及大鼠对直接 DA 受体激动剂阿扑吗啡(1.0 mg/kg 皮下注射)的运动反应,表明Δ(9)-THC 通过上调 NAcc 中突触后 DA 受体信号来敏化安非他命的运动反应。最后,在安非他命(5×1.5 mg/kg 腹腔注射)暴露的大鼠中,安非他命(200μg/kg/infusion 静脉注射)的自我给药增强,但在暴露于Δ(9)-THC(5×3.0 mg/kg 腹腔注射)的大鼠中则没有。以前暴露于该剂量的Δ(9)-THC 适度增加了阿扑吗啡的 SA(0.5 mg/kg/infusion 静脉注射)。因此,与安非他命暴露不同,暴露于Δ(9)-THC 不会增强随后对安非他命的 NAcc DA 反应或促进安非他命的自我给药。尽管Δ(9)-THC 导致 NAcc 中突触后 DA 受体信号的改变,这些改变可以影响运动的产生,但这些神经适应似乎与增强的安非他命自我给药的表达无关。

相似文献

1
Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine.先前暴露于 delta9-四氢大麻酚会增强对安非他命的运动反应,但不会增强其自身给药。
J Pharmacol Exp Ther. 2011 Jun;337(3):724-33. doi: 10.1124/jpet.111.180208. Epub 2011 Mar 9.
2
Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems.慢性 δ⁹-四氢大麻酚暴露会导致中脑边缘和黑质纹状体系统中的多巴胺 D₂/₃ 受体敏化。
Neuropsychopharmacology. 2012 Oct;37(11):2355-67. doi: 10.1038/npp.2012.91. Epub 2012 Jun 13.
3
Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine.伏隔核壳区短暂过表达α-Ca2+/钙调蛋白依赖性蛋白激酶 II 增强对安非他命的行为反应。
J Neurosci. 2010 Jan 20;30(3):939-49. doi: 10.1523/JNEUROSCI.4383-09.2010.
4
Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited.当谷氨酸再摄取受到抑制时,先前接触苯丙胺会增强随后对D1多巴胺受体激动剂的运动反应。
J Neurosci. 2001 Mar 1;21(5):RC133. doi: 10.1523/JNEUROSCI.21-05-j0003.2001.
5
Exposure to conditions of uncertainty promotes the pursuit of amphetamine.暴露于不确定的环境中会促进安非他命的追求。
Neuropsychopharmacology. 2019 Jan;44(2):274-280. doi: 10.1038/s41386-018-0099-4. Epub 2018 May 22.
6
SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine.SR 141716A,一种CB1大麻素受体拮抗剂,可增强苯丙胺和阿扑吗啡的运动兴奋作用。
Behav Pharmacol. 1999 Jul;10(4):429-32. doi: 10.1097/00008877-199907000-00010.
7
Inhibition of CaMKII in the nucleus accumbens shell decreases enhanced amphetamine intake in sensitized rats.伏隔核壳部的CaMKII受到抑制会减少致敏大鼠中增强的苯丙胺摄入量。
Neurosci Lett. 2008 Oct 24;444(2):157-60. doi: 10.1016/j.neulet.2008.08.004. Epub 2008 Aug 7.
8
Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.神经肽Y Y(1)受体拮抗剂BIBO 3304对苯丙胺和阿扑吗啡诱导的行为效应的抑制作用。
Neuropharmacology. 2000 Apr 27;39(7):1292-302. doi: 10.1016/s0028-3908(99)00199-9.
9
Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine.中脑多巴胺神经元反应性的敏化促进对安非他明的追求。
J Neurosci. 2002 Jun 1;22(11):4654-62. doi: 10.1523/JNEUROSCI.22-11-04654.2002.
10
Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).在北美短尾鼩鼱(Cryptotis parva)中,Δ⁹-四氢大麻酚对化学性质各异的多巴胺D2/D3受体激动剂所产生的呕吐和增强的运动活性具有不同的抑制作用。
Pharmacol Biochem Behav. 2005 Jan;80(1):35-44. doi: 10.1016/j.pbb.2004.10.019. Epub 2004 Dec 8.

引用本文的文献

1
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies.大麻素与苯丙胺共同暴露及其对生物、行为和健康结果的影响:动物和人类研究的范围综述。
Psychopharmacology (Berl). 2022 May;239(5):1211-1230. doi: 10.1007/s00213-021-05960-2. Epub 2021 Oct 6.
2
One Is Not Enough: Understanding and Modeling Polysubstance Use.一种并不够:理解和建模多物质使用。
Front Neurosci. 2020 Jun 16;14:569. doi: 10.3389/fnins.2020.00569. eCollection 2020.
3
Prenatal ethanol exposure increases risk of psychostimulant addiction.产前乙醇暴露会增加精神兴奋剂成瘾的风险。
Behav Brain Res. 2019 Jan 1;356:51-61. doi: 10.1016/j.bbr.2018.07.030. Epub 2018 Aug 1.
4
Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.大麻素奖赏的临床前研究、大麻使用障碍的治疗方法,以及大麻素暴露的成瘾相关效应。
Neuropsychopharmacology. 2018 Jan;43(1):116-141. doi: 10.1038/npp.2017.193. Epub 2017 Aug 28.
5
The effects of Δ-tetrahydrocannabinol on the dopamine system.Δ-四氢大麻酚对多巴胺系统的影响。
Nature. 2016 Nov 17;539(7629):369-377. doi: 10.1038/nature20153.
6
Exposure to nicotine enhances its subsequent self-administration: contribution of nicotine-associated contextual stimuli.接触尼古丁会增强其随后的自我给药行为:尼古丁相关情境刺激的作用。
Behav Brain Res. 2014 Mar 1;260:155-61. doi: 10.1016/j.bbr.2013.11.035. Epub 2013 Dec 1.
7
Previous exposure to nicotine enhances the incentive motivational effects of amphetamine via nicotine-associated contextual stimuli.先前接触尼古丁会通过与尼古丁相关的环境刺激增强安非他命的激励动机效应。
Neuropsychopharmacology. 2012 Sep;37(10):2277-84. doi: 10.1038/npp.2012.80. Epub 2012 May 23.
8
Unusual effects of nicotine as a psychostimulant on ambulatory activity in mice.尼古丁作为一种精神兴奋剂对小鼠活动能力的异常影响。
ISRN Pharmacol. 2012;2012:170981. doi: 10.5402/2012/170981. Epub 2012 Mar 20.

本文引用的文献

1
Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons.内源性大麻素和环磷酸腺苷/蛋白激酶 A 通路对中脑多巴胺神经元谷氨酸突触可塑性的调节。
J Physiol. 2010 Jul 15;588(Pt 14):2589-604. doi: 10.1113/jphysiol.2010.190066. Epub 2010 May 24.
2
Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.对Δ9-四氢大麻酚的行为敏化以及与吗啡的交叉敏化:伏隔核壳部和核心多巴胺传递的差异变化。
J Neurochem. 2008 Aug;106(4):1586-93. doi: 10.1111/j.1471-4159.2008.05503.x. Epub 2008 Jun 28.
3
Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.CB1受体在大鼠纹状体中的表达与功能:定位及其对D1和D2多巴胺受体介导的运动行为的影响。
Neuropsychopharmacology. 2008 Jun;33(7):1667-79. doi: 10.1038/sj.npp.1301558. Epub 2007 Oct 24.
4
Exposure to nicotine and sensitization of nicotine-induced behaviors.尼古丁暴露与尼古丁诱导行为的敏化
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15;31(8):1625-38. doi: 10.1016/j.pnpbp.2007.08.038. Epub 2007 Sep 1.
5
Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats.雄性青少年和成年大鼠对大麻素和“俱乐部药物”的敏感性及致敏性的年龄依赖性差异。
Addict Biol. 2008 Sep;13(3-4):277-86. doi: 10.1111/j.1369-1600.2007.00077.x. Epub 2007 Sep 11.
6
Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine.小鼠反复接触四氢大麻酚后缺乏行为敏化及其与甲基苯丙胺的比较。
Psychopharmacology (Berl). 2007 Sep;193(4):511-9. doi: 10.1007/s00213-007-0811-2. Epub 2007 May 12.
7
Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats.青少年接触大麻会改变成年大鼠的阿片类药物摄入量和阿片类边缘神经元群体。
Neuropsychopharmacology. 2007 Mar;32(3):607-15. doi: 10.1038/sj.npp.1301127. Epub 2006 Jul 5.
8
Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats.先前接触四氢大麻酚会改变可卡因对大鼠的强化效力及与焦虑相关的效应。
Neuropsychopharmacology. 2007 Mar;32(3):646-57. doi: 10.1038/sj.npp.1301109. Epub 2006 May 31.
9
Involvement of the endocannabinoid system in drug addiction.内源性大麻素系统与药物成瘾的关系。
Trends Neurosci. 2006 Apr;29(4):225-32. doi: 10.1016/j.tins.2006.01.008. Epub 2006 Feb 17.
10
Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens.靶向大鼠伏隔核中的多巴胺D2受体和大麻素1(CB1)受体。
J Comp Neurol. 2006 Mar 20;495(3):299-313. doi: 10.1002/cne.20881.